All articles by  

  1. ApolloBio to develop Inovio’s VGX-3100 in Greater China

    ApolloBio has signed an amended agreement to obtain exclusive development and commercialisation rights for Inovio Pharmaceuticals’ VGX-3100 in Greater China,…
    Read More…

    4 Jan
  2. Pfizer and Sangamo to develop zinc finger protein therapy for ALS

    Pfizer has partnered with US-based biotechnology firm Sangamo Therapeutics to use zinc finger protein transcription factors (ZFP-TFs) for the development…
    Read More…

    4 Jan
  3. FDA accepts sBLA of Seattle Genetics’ ADCETRIS for Hodgkin lymphoma

    The US Food and Drug Administration (FDA) has accepted filing of a supplemental biologics licence application (sBLA) by Seattle Genetics…
    Read More…

    4 Jan
  4. Biocon and Mylan’s biosimilar receives Brazilian regulatory approval

    Brazilian regulatory agency ANVISA has approved Biocon and Mylan’s biosimilar Trastuzumab through their partner Libbs Farmaceutica (Libbs). Co-developed by the…
    Read More…

    3 Jan
  5. J&J and Janssen face lawsuits over knee amputations due to Invokana

    US law firm Parker Waichman has filed two lawsuits against Johnson & Johnson (J&J) and Janssen Pharmaceuticals related to their…
    Read More…

    3 Jan
  6. ANI Pharma purchases US rights for four AstraZeneca products

    US-based ANI Pharmaceuticals has purchased the rights from AstraZeneca to market Atacand, Atacand HCT, Arimidex and Casodex tablets in the…
    Read More…

    3 Jan
  7. Mallinckrodt agrees to buy Sucampo Pharma for $1.2bn

    Mallinckrodt has signed an agreement to purchase all outstanding shares of Sucampo Pharmaceuticals for around $1.2bn. Under the agreement, Mallinckrodt…
    Read More…

    2 Jan
  8. Bayer’s partner Loxo Oncology initiates NDA for larotrectinib

    Bayer’s collaboration partner Loxo Oncology has initiated the submission of a rolling new drug application (NDA) for larotrectinib (LOXO-101) to…
    Read More…

    22 Dec
  9. Merck agrees to manufacture viral vectors for bluebird bio

    Merck has entered a commercial supply agreement with US-based bluebird bio to manufacture viral vectors for gene therapies. bluebird bio…
    Read More…

    22 Dec
  10. Boehringer partners with UK’s Autifony for CNS therapeutics

    UK-based biotechnology firm Autifony Therapeutics has entered an agreement with Boehringer Ingelheim regarding select aspects of its Kv3.1/3.2 voltage-gated potassium…
    Read More…

    21 Dec

Go Top